In-use stability assessment of FDA approved metformin immediate release and extended release products for N-Nitrosodimethylamine and dissolution quality attributes
Authors:
- 21 June 2022
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 623, 121923
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Effect of processing parameters and controlled environment storage on the disproportionation and dissolution of extended-release capsule of phenytoin sodiumInternational Journal of Pharmaceutics, 2018
- Long-term treatment study of global standard dose metformin in Japanese patients with type 2 diabetes mellitusDiabetology International, 2017
- Mechanism of Metformin: A Tale of Two SitesDiabetes Care, 2016
- Development and validation of an LC-MS/MS method for the determination of adapalene in pharmaceutical forms for skin applicationJournal of the Serbian Chemical Society, 2016
- Evaluation of In-Use Stability of Anticoagulant Drug Products: Warfarin SodiumJournal of Pharmaceutical Sciences, 2015
- Chemometrically assissted optimization and validation of RP-HPLC method for the analysis of itraconazole and its impuritiesActa Pharmaceutica, 2013
- Application of quality by design elements for the development and optimization of an analytical method for protamine sulfateJournal of Pharmaceutical and Biomedical Analysis, 2012
- Full and fractionated experimental designs for robustness testing in the high-performance liquid chromatographic analysis of codeine phosphate, pseudoephedrine hydrochloride and chlorpheniramine maleate in a pharmaceutical preparationJournal of Chromatography A, 2000
- Two level factorial experimental designs based on multiple linear regression models: a tutorial digest illustrated by case studiesAnalytica Chimica Acta, 1998
- Re-evaluation of a biguanide, metformin: mechanism of action and tolerabilityPharmacological Research, 1994